MOYOM fait progresser l'esthétique régénérative en Europe grâce à la certification APHRANEL® conforme au règlement MDR de l'UE et à une collaboration scientifique stratégique avec Expert2Expert

RegulatoryapprovedAPHRANEL®Positive

AI Analysis

Summary

MOYOM announced EU MDR certification for its APHRANEL® regenerative aesthetics product and established a strategic scientific collaboration with Expert2Expert to advance its European market strategy.

Outcome Details

EU MDR (Medical Devices Regulation) certification obtained for APHRANEL®

Importance:6/10

Sentiment:

0.70

medical deviceEU regulationregenerative aestheticsMDR compliancepartnershipEurope

Read the original article

Published by PR Newswire Biotech on August 3, 2026 3:18 AM

Read Original